Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Instead of waiting days or even weeks for the result of a prostate-specific antigen (PSA) test, physicians and their patients can now have the information in minutes, thanks to a novel device recently ...

The PSA test is an imperfect way to screen men for prostate cancer. But until recently, it was seen as the best option available. The test measures the amount of prostate specific antigen, or PSA, in ...

Oct. 14, 2003 — Complexed prostate-specific antigen (cPSA) as a single test improved specificity over total PSA, according to the results of a prospective study published in the November issue of the ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Please provide your email address to receive an email when new articles are posted on . A novel blood test was more accurate than PSA screening for identifying patients with high-risk prostate cancer, ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...